Certainly true. Burns used to be a miserable death sentence. Not sure that BTM will improve survival, but it looks like it will improve functional and aesthetic outcomes at a lower cost. Come a long way in 25 years.
- Forums
- ASX - By Stock
- PNV
- Ann: First US Surgeon Podium presentations of Novosorb BTM
Ann: First US Surgeon Podium presentations of Novosorb BTM, page-19
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.27 |
Change
-0.030(1.30%) |
Mkt cap ! $1.553B |
Open | High | Low | Value | Volume |
$2.33 | $2.34 | $2.24 | $1.508M | 661.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 2276 | $2.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.28 | 32657 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
49 | 20848 | 2.250 |
23 | 57947 | 2.240 |
14 | 135913 | 2.230 |
12 | 47045 | 2.220 |
12 | 37167 | 2.210 |
Price($) | Vol. | No. |
---|---|---|
2.260 | 10338 | 12 |
2.270 | 45811 | 19 |
2.280 | 64917 | 19 |
2.290 | 18995 | 8 |
2.300 | 25804 | 15 |
Last trade - 14.56pm 15/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online